MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
38.39
-1.36 (-3.41%)
May 9, 2025, 4:00 PM - Market closed
MLTX Market Cap
MLTX has a market cap or net worth of $2.43 billion as of May 9, 2025. Its market cap has decreased by -8.95% in one year.
Market Cap
2.43B
Enterprise Value
1.99B
1-Year Change
-8.95%
Ranking
Category
Stock Price
$38.39
Market Cap Chart
Since February 14, 2022, MLTX's market cap has increased from $3.60M to $2.43B, an increase of 67,411.23%. That is a compound annual growth rate of 650.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 2.43B | -28.71% |
| Dec 31, 2024 | 3.41B | -5.66% |
| Dec 29, 2023 | 3.62B | 784.47% |
| Dec 30, 2022 | 409.26M | 11,274.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.60B |
| Johnson & Johnson | 374.53B |
| UnitedHealth Group | 349.75B |
| AbbVie | 328.29B |
| Novo Nordisk | 287.72B |
| Abbott Laboratories | 233.14B |
| Novartis AG | 215.89B |
| AstraZeneca | 208.98B |